Array BioPharma, Inc. (NASDAQ:ARRY)
| CAPS Rating |
|
|---|---|
| Open | $2.59 |
| Previous Close | $2.60 |
| Daily Range | $2.55 - $2.72 |
| 52-Week Range | $1.58 - $3.41 |
| Market Cap | $151.67M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,227,864 |
| Average Daily Volume | 0 |
ARRY
VS S&P 500 (SPY)
How do you think ARRY will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ARRY Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ARRY News and Commentary
- Company News for February 10, 2012 - Corporate Summary – NASDAQ
- Array BioPharma Outruns Estimates Again – The Motley Fool
- Value Ideas: 10 Undervalued Stocks with a History of Earning Surprises – NASDAQ
- 10 Biotech Stocks Trading at Deep Discounts to Analyst Target Prices – NASDAQ
- This Week in Biotech – The Motley Fool
- BioPharma Lung Cancer Drug Fails to Meet Main Goal in Study – Fox Business
- Why SuperGen's Earnings Are Outstanding – The Motley Fool
- Future Biotech Superstars – SeekingAlpha
- 3 Biotech Stocks on Our ASCO Watchlist – SeekingAlpha
- Here's How SuperGen Is Making You So Much Cash – The Motley Fool
- 7 Biotech Penny Stocks to Buy – NASDAQ
- Array BioPharma CEO Discusses F1Q2011 Results - Earnings Call Transcript – SeekingAlpha
- Array BioPharma CEO Discusses F1Q2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Celgene Is All Grown Up – The Motley Fool
- Can Array BioPharma Attract Yet Another Partner? – SeekingAlpha
- Array Biopharma: A Wall Street Anomaly – SeekingAlpha
- Array BioPharma Inc. F4Q10 (Qtr End 06/30/10) Earnings Call Transcript – SeekingAlpha
- Array BioPharma Inc. F4Q10 (Qtr End 06/30/10) Earnings Call Transcript – SeekingAlpha Transcripts
- A Big Upgrade for Novartis – The Motley Fool
- 5 Stocks Breaking Out – The Motley Fool
RSS Headlines
Fool UK
